09 April 2024
The city authorities have decided to include drugs containing the active substance inclisiran. It is in the list of free drugs provided to Muscovites with hyperlipidemia. The corresponding resolution was signed by Sergei Sobyanin. In 2023, over 169 thousand Muscovites were provided with free drugs.
The urban healthcare practice made the decision to use this medicine based on the results of an observational efficacy study conducted by the Department of Health in the capital in 2023.
Since 2020, Moscow has been running a program aimed at providing free medication to citizens suffering from cardiovascular diseases. This initiative encompasses drugs for a total of 33 international generic names. Medicines are given to patients at high risk of developing cardiovascular diseases, those who have had a heart attack or stroke, and those suffering from other diseases of the circulatory system.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024